Clinical trial

Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use…

NCT00237822 · Yale University, Other · Completed

Key facts

NCT number NCT00237822
Title Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use Disorders
Official title Increasing Treatment Adherence in Co-Occurring Disorders
Lead sponsor Yale University, Other
Collaborators National Institute on Drug Abuse (NIDA) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Diagnosis, Dual (Psychiatry), Psychiatric Diagnosis, Drug Use Disorders
Intervention type Behavioral
Interventions Adherence Feedback (AF), AF + Contingency Management (AF + CM), AF + Motivational Enhancement Therapy (AF + MET)
Enrollment 75
Start date Sep 1, 2003
Completion Dec 1, 2007
First posted Oct 12, 2005
Last update posted Oct 17, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies